Holdbacks are very common in purchasing agreements. They are usually a portion of money that is not paid at the end of term, typically help by a..
There is not much room for error when it comes to negotiating budgets for clinical trials. Through the experiences of the sites in our network, we have..
Negotiating a clinical trial budget isn’t rocket science, but it is most certainly an art form. You don’t need to be an expert, but you should..
Scott Palmese, VP of Site Networks
BTC Network’s Scott Palmese answers common questions regarding start-up fees, fair market value, monitor change fees and more.
As medical research advances, clinical trial protocols are becoming more detailed, resulting in more complicated budgets. Having a thorough and..
Below are some questions we received during the presentation.